Cargando…

Determining Pharmacological Mechanisms of Chinese Incompatible Herbs Fuzi and Banxia in Chronic Obstructive Pulmonary Disease: A Systems Pharmacology-Based Study

Aconiti Lateralis Radix Praeparata (Fuzi) and Pinelliae Rhizoma (Banxia) are among the 18 incompatible medications that are forbidden from use in one formulation. However, there is increasing evidence implying that this prohibition is not entirely correct. According to the theory of Chinese traditio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Kaiwen, Cai, Xiaolu, Chen, Yaling, Zhou, Linshui, Chen, Ruilin, Zheng, Suqun, Wang, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790578/ https://www.ncbi.nlm.nih.gov/pubmed/33488748 http://dx.doi.org/10.1155/2020/8365603

Ejemplares similares

Effects and Components of Herb Pair Huanglian-Banxia on Diabetic Gastroparesis by Network Pharmacology
por: Liang, Guoqiang, et al.
Publicado: (2021)

Uncovering the pharmacological mechanism of the effects of the Banxia-Xiakucao Chinese Herb Pair on sleep disorder by a systems pharmacology approach
por: Guo, Jing, et al.
Publicado: (2020)

The Network Pharmacology Study of Dahuang Fuzi Decoction for Treating Incomplete Intestinal Obstruction
por: Guo, Jun-feng, et al.
Publicado: (2022)

The mechanism of Renshen-Fuzi herb pair for treating heart failure—Integrating a cardiovascular pharmacological assessment with serum metabolomics
por: Chen, Xiaofei, et al.
Publicado: (2022)

The pharmacology of Chinese herbs /
por: Huang, K. C. (Kee Chang), 1917-
Publicado: (1999)

A Systems Pharmacology Approach for Identifying the Multiple Mechanisms of Action for the Rougui-Fuzi Herb Pair in the Treatment of Cardiocerebral Vascular Diseases
por: Li, Chun, et al.
Publicado: (2020)

Fuzi and Banxia Combination, Eighteen Antagonisms in Chinese Medicine, Aggravates Adriamycin-Induced Cardiomyopathy Associated with PKA/β2AR-Gs Signaling
por: Sun, Fengjiao, et al.
Publicado: (2018)

Identification of the significant pathways of Banxia Houpu decoction in the treatment of depression based on network pharmacology
por: Chen, Zi-ying, et al.
Publicado: (2020)

Banxia Xiexin decoction: A review on phytochemical, pharmacological, clinical and pharmacokinetic investigations
por: Zhou, Zehua, et al.
Publicado: (2023)

Banxia baizhu tianma decoction, a Chinese herbal formula, for hypertension: Integrating meta-analysis and network pharmacology
por: Lin, Jianguo, et al.
Publicado: (2022)

Revealing the efficacy-toxicity relationship of Fuzi in treating rheumatoid arthritis by systems pharmacology
por: Feng, Wuwen, et al.
Publicado: (2021)

Exploring the mechanisms of neurotoxicity caused by fuzi using network pharmacology and molecular docking
por: An, Junsha, et al.
Publicado: (2022)

Therapeutic effects of shaogan fuzi decoction in rheumatoid arthritis: Network pharmacology and experimental validation
por: Shi, Lu, et al.
Publicado: (2022)

Transcriptome-Wide m6A Methylome and m6A-Modified Gene Analysis in Asthma
por: Sun, Deyang, et al.
Publicado: (2022)

Exploring the role and mechanism of Fuzi decoction in the treatment of osteoporosis by integrating network pharmacology and experimental verification
por: Li, Fudong, et al.
Publicado: (2023)

Exploration of the Molecular Mechanism of FUZI (Aconiti Lateralis Radix Praeparata) in Allergic Rhinitis Treatment Based on Network Pharmacology
por: Chen, Xiangjing, et al.
Publicado: (2020)

Investigation of Molecular Mechanism of Banxia Xiexin Decoction in Colon Cancer via Network Pharmacology and In Vivo Studies
por: Ma, Lili, et al.
Publicado: (2022)

An Integrated Gut Microbiota and Network Pharmacology Study on Fuzi-Lizhong Pill for Treating Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhen, Zhang, et al.
Publicado: (2021)

Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of BanXia-YiYiRen in treating insomnia
por: Wang, Liang, et al.
Publicado: (2022)

os fuzis
Publicado: (1990)

Identification of the effect and mechanism of Yiyi Fuzi Baijiang powder against colorectal cancer using network pharmacology and experimental validation
por: Xiang, Bin, et al.
Publicado: (2022)

Identification of Active Compounds of Mahuang Fuzi Xixin Decoction and Their Mechanisms of Action by LC-MS/MS and Network Pharmacology
por: Liang, Xiao, et al.
Publicado: (2020)

Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module
por: Yu, Ying, et al.
Publicado: (2020)

The pharmacological mechanism of Chinese herbs effective in treating advanced ovarian cancer: Integrated meta-analysis and network pharmacology analysis
por: Yang, Ze, et al.
Publicado: (2022)

Mining Important Herb Combinations of Traditional Chinese Medicine against Hypertension Based on the Symptom-Herb Network Combined with Network Pharmacology
por: Sun, Zhenhai, et al.
Publicado: (2022)

Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology
por: Gao, Li, et al.
Publicado: (2016)

Nauclea officinalis: A Chinese medicinal herb with phytochemical, biological, and pharmacological effects
por: Liu, Bin, et al.
Publicado: (2022)

Heart Protection by Herb Formula BanXia BaiZhu TianMa Decoction in Spontaneously Hypertensive Rats
por: Jiang, Jiaye, et al.
Publicado: (2019)

Mechanisms of Banxia Xiexin Decoction Underlying Chronic Atrophic Gastritis via Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations
por: Chang, Cheng, et al.
Publicado: (2022)

Pharmacologic therapies of ARDS: From natural herb to nanomedicine
por: Meng, Linlin, et al.
Publicado: (2022)

Acquired crizotinib-resistant pulmonary adenocarcinoma and subsequent primary gallbladder cancer: A case report
por: Zhang, Min, et al.
Publicado: (2023)

Pharmacokinetic incompatibility of the Huanglian-Gancao herb pair
por: Zhang, Ji-Quan, et al.
Publicado: (2020)

Efficacy and Safety of Banxia XieXin Decoction, a Blended Traditional Chinese Medicine, as Monotherapy for Patients With Advanced Hepatocellular Carcinoma
por: Wang, Lijuan, et al.
Publicado: (2020)

Molecular targets of Chinese herbs: a clinical study of metastatic colorectal cancer based on network pharmacology
por: Zhu, Hongxu, et al.
Publicado: (2018)

CancerHSP: anticancer herbs database of systems pharmacology
por: Tao, Weiyang, et al.
Publicado: (2015)

Pharmacological effectiveness of the active phytochemicals contained in foods and herbs
por: Satoh, Hiroyasu
Publicado: (2014)

Diterpenoid Alkaloids from the Chinese Traditional Herbal “Fuzi” and Their Cytotoxic Activity
por: Gao, Feng, et al.
Publicado: (2012)

Systems Pharmacology–Based Dissection of Anti-Cancer Mechanism of Traditional Chinese Herb Saussurea involucrata
por: Zhang, Qian, et al.
Publicado: (2021)

Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking
por: Luo, Zheng, et al.
Publicado: (2022)

Fuling-Guizhi Herb Pair in Coronary Heart Disease: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation
por: Duan, Bailu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d19ar5pgkndf1pm9srdobq45ds